Selective thyromimetics: tissue-selective thyroid hormone analogs

T S Scanlan1, H A Yoshihara, N H Nguyen

  • 1Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California-San Francisco, San Francisco, CA 94143-0446, USA. scanlan@cgl.ucsf.edu

Current Opinion in Drug Discovery & Development
|June 27, 2003
PubMed

Insights

Developing selective thyromimetics offers a promising approach to target tissue-specific thyroid hormone actions. These compounds can help treat metabolic disorders by selectively modulating thyroid hormone receptor pathways.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Pharmacology

Background:

  • Thyroid hormone is crucial for development and homeostasis, with actions mediated by tissue-specific receptor isoforms.
  • Dysregulation of these tissue-specific pathways is linked to metabolic diseases.

Purpose of the Study:

  • To explore the development of synthetic thyroid hormone analogs with tissue-selective actions (selective thyromimetics).
  • To investigate the potential therapeutic applications of these selective thyromimetics in metabolic disorders.

Main Methods:

  • Utilizing tools such as receptor binding and activation assays.
  • Employing receptor structural data and thyroid hormone receptor knockout mouse models.
  • Applying medicinal chemistry approaches to design and synthesize selective thyromimetics.

Main Results:

  • Demonstrated that selective thyromimetics can be produced through various medicinal chemistry strategies.
  • These compounds serve as valuable probes for elucidating thyroid hormone actions.

Conclusions:

  • Selective thyromimetics represent a viable strategy for modulating tissue-specific thyroid hormone signaling.
  • These compounds hold potential for future clinical use in treating metabolic disorders.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...